New publications in health economics and genomics 30th November 2021

One publication from the past week:

  • Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 23rd November 2021

Two publications from the past week:

  • The diagnostic trajectory of infants and children with clinical features of genetic disease | link
  • Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 16th November 2021

Three publications from the past week:

  • Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis | link
  • 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report | link
  • Returning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 2nd November 2021

Three publications from the past week:

  • Incomplete information and irrelevant attributes in stated-preference values for health interventions | link
  • The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group | link
  • Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 26th October 2021

Three publications from the past week (there were no publications in the rest of October, hence the radio silence!):

  • Quantifying the Impact of Capacity Constraints in Economic Evaluations: An Application in Precision Medicine | link
  • The Value of Genomic Testing: A Contingent Valuation Across Six Child- and Adult-Onset Genetic Conditions | link
  • Conceptualization of utility in translational clinical genomics research | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 28th September 2021

Two publications from the past week:

  • Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessments | link
  • Comprehensive genomic profiling for non-small-cell lung cancer: health and budget impact | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 21st September 2021

One publication from the past week:

  • Patient and public preferences for being recontacted with updated genomic results: a mixed methods study | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 14th September 2021

One publication from the past week:

  • Cost effectiveness of targeted exome analysis as a diagnostic test in glomerular diseases | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 31st August 2021

One publication from the past week:

  • Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 24th August 2021

Four publications from the past week:

  • The clinical utility of exome and genome sequencing across clinical indications: a systematic review | link
  • Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer | link
  • Effectiveness of clinical exome sequencing in adult patients with difficult-to-diagnose neurological disorders | link
  • Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in Scotland | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.